Literature DB >> 14575692

Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains.

Masako Tanabe1, Mitsue Kurita-Taniguchi, Kaoru Takeuchi, Makoto Takeda, Minoru Ayata, Hisashi Ogura, Misako Matsumoto, Tsukasa Seya.   

Abstract

PolyI:C, a synthetic double-stranded (ds)RNA, and viruses act on cells to induce IFN-beta which is a key molecule for anti-viral response. Although dsRNA is a virus-specific signature and a ligand for human Toll-like receptor 3 (TLR3), largely uncharacterized multiple pathways associate virus-mediated IFN-beta induction. Here, we demonstrated that laboratory-adapted but not wild-type strains of measles virus (MV) up-regulated TLR3 expression both in dendritic cells and epithelial cell line A549. The kinetics experiments with the laboratory MV strain revealed that TLR3 was induced late compared to IFN-beta and required new protein synthesis. Furthermore, neutralizing antibodies against IFN-beta or IFNAR (Interferon-alpha/beta receptor) suppressed MV-induced TLR3 induction, indicating that type I IFN, IFN-alpha/beta, is critical for MV-mediated TLR3 induction. Yet, a recently identified virus-inducible IFN, the IFN-lambda, did not contribute to TLR3 expression. A virus-responsive element that up-regulates TLR3 was identified in the TLR3-promoter region by reporter gene experiments. The ISRE, a recently reported site for IFN-beta induction, but not STAT binding site, located around -30bp of TLR3 promoter responded to MV to induce TLR3 expression. This further indicates the importance of type I IFN for TLR3 up-regulation in the case of viral infection. In HeLa and MRC5 cells, augmented production of IFN-beta was observed in response to dsRNA when TLR3 had been induced beforehand. Thus, the MV-induced expression of TLR3 may reflect amplified IFN production that plays a part in host defense to viral infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575692     DOI: 10.1016/j.bbrc.2003.09.159

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Hum Genet       Date:  2011-03-19       Impact factor: 4.132

Review 2.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

3.  Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results.

Authors:  Neelam Dhiman; Inna G Ovsyannikova; Robert A Vierkant; Jenna E Ryan; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

4.  p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines.

Authors:  Manabu Taura; Ayaka Eguma; Mary Ann Suico; Tsuyoshi Shuto; Tomoaki Koga; Kensei Komatsu; Takefumi Komune; Takashi Sato; Hideyuki Saya; Jian-Dong Li; Hirofumi Kai
Journal:  Mol Cell Biol       Date:  2008-09-08       Impact factor: 4.272

5.  Association of Toll-Like Receptor 3 and Toll-Like Receptor 9 Single Nucleotide Polymorphisms with Hepatitis C Virus Infection and Hepatic Fibrosis in Egyptian Patients.

Authors:  Rania A Zayed; Dalia Omran; Doha A Mokhtar; Zinab Zakaria; Sameera Ezzat; Mohamed A Soliman; Lamiaa Mobarak; Hossam El-Sweesy; Ghada Emam
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

6.  Engineering oncolytic measles virus to circumvent the intracellular innate immune response.

Authors:  Iana Haralambieva; Ianko Iankov; Kosei Hasegawa; Mary Harvey; Stephen J Russell; Kah-Whye Peng
Journal:  Mol Ther       Date:  2007-01-16       Impact factor: 11.454

7.  TLR3 activation efficiency by high or low molecular mass poly I:C.

Authors:  Yu Zhou; Ming Guo; Xu Wang; Jielang Li; Yizhong Wang; Li Ye; Ming Dai; Li Zhou; Yuri Persidsky; Wenzhe Ho
Journal:  Innate Immun       Date:  2012-10-03       Impact factor: 2.680

8.  Localization of type I interferon receptor limits interferon-induced TLR3 in epithelial cells.

Authors:  Jonathan M Ciencewicki; Luisa E Brighton; Ilona Jaspers
Journal:  J Interferon Cytokine Res       Date:  2009-05       Impact factor: 2.607

Review 9.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 10.  Application of pharmacogenomics to vaccines.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Pharmacogenomics       Date:  2009-05       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.